FDA Center For Biologics Evaluation and Research

Print this page         

FDA's Center for Biologics Evaluation and Research regulates the following products: allergenic extracts, monoclonal antibodies, biotech derived therapeutics, somatic cell and gene therapy, xenotransplantation, tissues, some devices, whole blood, blood components, blood derivatives, and vaccines.

Issues Concerning Blood, Biologics,and Biotechnology 

Last Update: 19 September 2011


  • Click to go to My Communities of Practice
  • Click to go to My Affiliate or Chapter
  • Click to go to My Profile
Click to go to the Member Gift